Higher levels of ATX have, for example, been found in MCI and AD patients and correlated with hypometabolism at fluorodeoxyglucose (FDG)-PET in medial temporal lobe, lower scores on tests of executive function and memory, reduced cortical thickness in the prefrontal cortex and CSF biomarkers of AD [246]. The gene discussed is ENPP2; the disease is Alzheimer disease.